The next decade in mechanical assist: Advances that will help the patient and the doctor

Current Opinion in Cardiology

Volumn 26, Issue 3, 2011, Pages 256-260

  Atluri, Pavan ^a   Acker, Michael A ^a   Jessup, Mariell ^b  

^a Division of Vascular Surgery   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

complications; mechanical circulatory support; partial assist; technology; ventricular assist device

Indexed keywords

AORTA VALVE REGURGITATION; ARTICLE; ASSISTED CIRCULATION; BLEEDING; HEART ASSIST DEVICE; HEART FAILURE; HUMAN; IMPLANTATION; MORBIDITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME;

HEART FAILURE; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; PATIENT CARE; PHYSICIANS; QUALITY OF LIFE; TIME FACTORS;

EID: 79955073514     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328345af65     Document Type: Article

References (25)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics: 2010 update: a report from the American Heart Association. Circulation 2010; 121:e46-e215.
2. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report: 2010. J Heart Lung Transplant 2010; 29:1089-1103.
3. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001; 345:1435-1443.
4. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361:2241-2251.
5. Hayes HM, Dembo LG, Larbalestier R, et al. Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: a single-center experience. Artif Organs 2010; 34:703-706.
6. Letsou GV, Shah N, Gregoric ID, et al. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant 2005; 24:105-109. (Pubitemid 40094003)
7. Stern DR, Kazam J, Edwards P, et al. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg 2010; 25:352-356.
8. John R, Kamdar F, Liao K, et al. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-totransplant therapy. Ann Thorac Surg 2008; 86:1227-1234; discussion 1234-1235.
9. Crow S, John R, Boyle A, et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 2009; 137:208-215.
10. Genovese EA, Dew MA, Teuteberg JJ, et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg 2009; 88:1162-1170.
11. John R, Kamdar F, Liao K, et al. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. J Thorac Cardiovasc Surg 2008; 136:1318-1323.
12. Boyle AJ, Russell SD, Teuteberg JJ, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anticoagulation. J Heart Lung Transplant 2009; 28:881-887.
13. Genovese EA, Dew MA, Teuteberg JJ, et al. Early adverse events as predictors of 1-year mortality during mechanical circulatory support. J Heart Lung Transplant 2010; 29:981-988.
14. Uriel N, Pak SW, Jorde UP, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 2010; 56:1207-1213.
15. Meyer AL, Malehsa D, Bara C, et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 2010; 3:675-681.
16. Heilmann C, Geisen U, Beyersdorf F, et al. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart. Thromb Haemost 2010; 103:962-967.
17. Cowger J, Pagani FD, Haft JW, et al. The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail 2010; 3:668-674.
18. Pak SW, Uriel N, Takayama H, et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transplant 2010; 29:1172-1176.
19. Mudd JO, Cuda JD, Halushka M, et al. Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. J Heart Lung Transplant 2008; 27:1269-1274.
20. Awad H, Abd El Dayem M, Heard J, et al. Initial experience with off-pump left ventricular assist device implantation in single center: retrospective analysis. J Cardiothorac Surg 2010; 5:123.
21. Wieselthaler GM, O Driscoll G, Jansz P, et al. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multiinstitutional trial. J Heart Lung Transplant 2010; 29:1218-1225.
22. Meyns BP, Simon A, Klotz S, et al. Clinical benefits of partial circulatory support in New York Heart Association Class IIIB and Early Class IV patients. Eur J Cardiothorac Surg 2010. [Epub ahead of print]
23. Klotz S, Meyns B, Simon A, et al. Partial mechanical long-term support with the CircuLite Synergy pump as bridge-to-transplant in congestive heart failure. Thorac Cardiovasc Surg 2010; 58 (Suppl 2):S173-S178.
24. Lietz K, Long JW, Kfoury AG, et al. Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998-2005. Circ Heart Fail 2009; 2:3-10.
25. Holman WL, Pae WE, Teutenberg JJ, et al. INTERMACS: interval analysis of registry data. J Am Coll Surg 2009; 208:755-761; discussion 761-762.